CS200506B2 - Process for preparing 9,10-dohydroergosine and physiological additive salts with acids - Google Patents

Process for preparing 9,10-dohydroergosine and physiological additive salts with acids Download PDF

Info

Publication number
CS200506B2
CS200506B2 CS771451A CS145177A CS200506B2 CS 200506 B2 CS200506 B2 CS 200506B2 CS 771451 A CS771451 A CS 771451A CS 145177 A CS145177 A CS 145177A CS 200506 B2 CS200506 B2 CS 200506B2
Authority
CS
Czechoslovakia
Prior art keywords
dihydroergosine
methanesulfonate
effect
ergosine
reaction
Prior art date
Application number
CS771451A
Other languages
Czech (cs)
English (en)
Inventor
Rudolf Rucman
Nebojsa Djordjevic
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of CS200506B2 publication Critical patent/CS200506B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS771451A 1976-03-04 1977-03-03 Process for preparing 9,10-dohydroergosine and physiological additive salts with acids CS200506B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU545/76A YU40275B (en) 1976-03-04 1976-03-04 Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof

Publications (1)

Publication Number Publication Date
CS200506B2 true CS200506B2 (en) 1980-09-15

Family

ID=25550399

Family Applications (1)

Application Number Title Priority Date Filing Date
CS771451A CS200506B2 (en) 1976-03-04 1977-03-03 Process for preparing 9,10-dohydroergosine and physiological additive salts with acids

Country Status (11)

Country Link
JP (1) JPS52156900A (de)
AT (1) AT352301B (de)
BE (1) BE851961A (de)
CS (1) CS200506B2 (de)
DD (1) DD128612A5 (de)
DE (1) DE2708042A1 (de)
FR (1) FR2342979A1 (de)
HU (1) HU173239B (de)
NL (1) NL7702332A (de)
SE (1) SE7702254L (de)
YU (1) YU40275B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016187522A1 (en) * 2015-05-20 2016-11-24 Noramco, Inc. Process for the preparation of oxymorphone freebase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1216213A (fr) * 1954-12-03 1960-04-22 Cilag Spa Procédé de préparation de composés dihydrogénés des dérivés synthétiques ou naturels d'acide lysergique
GB1011112A (en) * 1961-05-10 1965-11-24 Sandoz Ag Improvements in or relating to ergot alkaloids
CH602765A5 (de) * 1974-09-27 1978-07-31 Sandoz Ag

Also Published As

Publication number Publication date
YU40275B (en) 1985-12-31
ATA134577A (de) 1979-02-15
BE851961A (fr) 1977-07-01
FR2342979A1 (fr) 1977-09-30
DD128612A5 (de) 1977-11-30
FR2342979B1 (de) 1980-10-03
JPS52156900A (en) 1977-12-27
AT352301B (de) 1979-09-10
SE7702254L (sv) 1977-09-05
NL7702332A (nl) 1977-09-06
HU173239B (hu) 1979-03-28
DE2708042A1 (de) 1977-09-08
YU54576A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
PL126313B1 (en) Process for preparing novel derivatives of 8-methylergoline
US4072759A (en) Novel benzylalcohol derivatives as antidiabetics and cardiotonics
HUT65396A (en) Process for producing piperidine derivatives and pharmaceutical preparations containing them
KR20140006111A (ko) 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
SK280731B6 (sk) 8-substituované 2-aminotetralíny, spôsob ich výrob
DE3880022T2 (de) Cycloalkylamide von (8beta)-1-alkyl-6-(substituierten) ergolinen.
US4528289A (en) Corynantheine derivates, processes for their preparation, and their use
JPH0631262B2 (ja) オクタヒドロチアゾロ［４，５−ｇキノリン類
JPS62226963A (ja) 選択的アルフア−アドレナリン受容体きつ抗剤
CS200506B2 (en) Process for preparing 9,10-dohydroergosine and physiological additive salts with acids
JPS62473A (ja) ジアルキルアミノテトラヒドロベンゾチアゾ−ルおよびオキサゾ−ル
JPS5813542B2 (ja) シンキエルゴリンユウドウタイノ セイホウ
JPH01268634A (ja) 心臓不整脈治療用医薬の製造でのキノリジンとキノリジノン誘導体の用途
JPS61165324A (ja) 心臓脈管系疾患治療剤
US4470990A (en) 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
TW200934760A (en) Indoline compounds
US4528290A (en) Stimulating dopamine D-1 receptors
CA1149801A (en) Ergol-8-ene and ergolin compounds and process for preparing same
JPH09291089A (ja) 新規な５−チアゾリルウラシル誘導体又はその塩
US3952021A (en) α-(3,4-Dimethoxyphenethylaminomethyl)-3,4 or 3,5-dihydroxybenzylalcohols and salts thereof
US5096929A (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them
JPH03167184A (ja) Ｎ―ベンジルトロパンアミド類
US4440772A (en) Acid addition salts of dextrorotatory ergot alkaloids, a process for the preparation thereof as well as their use as medicines
JP4223237B2 (ja) ３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法
US4558052A (en) 10-Bromosandwicine, 10-bromoisosandwicine, pharmaceutical compositions thereof, and methods of treating heart rhythm disorders with them